Literature DB >> 18840023

Impact of stratification on adverse drug reaction surveillance.

Johan Hopstadius1, G Niklas Norén, Andrew Bate, I Ralph Edwards.   

Abstract

BACKGROUND AND OBJECTIVES: Automated screening for excessive adverse drug reaction (ADR) reporting rates has proven useful as a tool to direct clinical review in large-scale drug safety signal detection. Some measures of disproportionality can be adjusted to eliminate any undue influence on the ADR reporting rate of covariates, such as patient age or country of origin, by using a weighted average of stratum-specific measures of disproportionality. Arguments have been made in favour of routine adjustment for a set of common potential confounders using stratification. The aim of this paper is to investigate the impact of using adjusted observed-to-expected ratios, as implemented for the Empirical Bayes Geometric Mean (EBGM) and the information component (IC) measures of disproportionality, for first-pass analysis of the WHO database.
METHODS: A simulation study was carried out to investigate the impact of simultaneous adjustment for several potential confounders based on stratification. Comparison between crude and adjusted observed-to-expected ratios were made based on random allocation of reports to a set of strata with a realistic distribution of stratum sizes. In a separate study, differences between the crude IC value and IC values adjusted for (combinations of) patient sex, age group, reporting quarter and country of origin, with respect to their concordance with a literature comparison were analysed. Comparison was made to the impact on signal detection performance of a triage criterion requiring reports from at least two countries before a drug-ADR pair was highlighted for clinical review.
RESULTS: The simulation study demonstrated a clear tendency of the adjusted observed-to-expected ratio to spurious (and considerable) underestimation relative to the crude one, in the presence of any very small strata in a stratified database. With carefully implemented stratification that did not yield any very small strata, this tendency could be avoided. Routine adjustment for potential confounders improved signal detection performance relative to the literature comparison, but the magnitude of the improvement was modest. The improvement from the triage criterion was more considerable. DISCUSSION AND
CONCLUSIONS: Our results indicate that first-pass screening based on observed-to-expected ratios adjusted with stratification may lead to missed signals in ADR surveillance, unless very small strata are avoided. In addition, the improvement in signal detection performance due to routine adjustment for a set of common confounders appears to be smaller than previously assumed. Other approaches to improving signal detection performance such as the development of refined triage criteria may be more promising areas for future research.

Entities:  

Mesh:

Year:  2008        PMID: 18840023     DOI: 10.2165/00002018-200831110-00008

Source DB:  PubMed          Journal:  Drug Saf        ISSN: 0114-5916            Impact factor:   5.606


  25 in total

1.  A retrospective evaluation of a data mining approach to aid finding new adverse drug reaction signals in the WHO international database.

Authors:  M Lindquist; M Ståhl; A Bate; I R Edwards; R H Meyboom
Journal:  Drug Saf       Date:  2000-12       Impact factor: 5.606

2.  Use of measures of disproportionality in pharmacovigilance: three Dutch examples.

Authors:  Antoine C G Egberts; Ronald H B Meyboom; Eugène P van Puijenbroek
Journal:  Drug Saf       Date:  2002       Impact factor: 5.606

3.  A data mining approach for signal detection and analysis.

Authors:  Andrew Bate; Marie Lindquist; I Ralph Edwards; Roland Orre
Journal:  Drug Saf       Date:  2002       Impact factor: 5.606

4.  Practical pharmacovigilance analysis strategies.

Authors:  A Lawrence Gould
Journal:  Pharmacoepidemiol Drug Saf       Date:  2003 Oct-Nov       Impact factor: 2.890

5.  Extending the methods used to screen the WHO drug safety database towards analysis of complex associations and improved accuracy for rare events.

Authors:  G Niklas Norén; Andrew Bate; Roland Orre; I Ralph Edwards
Journal:  Stat Med       Date:  2006-11-15       Impact factor: 2.373

6.  Comparative performance of two quantitative safety signalling methods: implications for use in a pharmacovigilance department.

Authors:  June S Almenoff; Karol K LaCroix; Nancy A Yuen; David Fram; William DuMouchel
Journal:  Drug Saf       Date:  2006       Impact factor: 5.606

7.  A Bayesian neural network method for adverse drug reaction signal generation.

Authors:  A Bate; M Lindquist; I R Edwards; S Olsson; R Orre; A Lansner; R M De Freitas
Journal:  Eur J Clin Pharmacol       Date:  1998-06       Impact factor: 2.953

8.  Spontaneous reporting of adverse drug reactions. II: Uses.

Authors:  M D Rawlins
Journal:  Br J Clin Pharmacol       Date:  1988-07       Impact factor: 4.335

9.  Safety related drug-labelling changes: findings from two data mining algorithms.

Authors:  Manfred Hauben; Lester Reich
Journal:  Drug Saf       Date:  2004       Impact factor: 5.606

10.  Pharmacovigilance in the 21st century: new systematic tools for an old problem.

Authors:  Ana Szarfman; Joseph M Tonning; P Murali Doraiswamy
Journal:  Pharmacotherapy       Date:  2004-09       Impact factor: 4.705

View more
  20 in total

1.  Identifying adverse events of vaccines using a Bayesian method of medically guided information sharing.

Authors:  Colin John Crooks; David Prieto-Merino; Stephen J W Evans
Journal:  Drug Saf       Date:  2012-01-01       Impact factor: 5.606

2.  Vaccine-based subgroup analysis in VigiBase: effect on sensitivity in paediatric signal detection.

Authors:  Sandra de Bie; Katia M C Verhamme; Sabine M J M Straus; Bruno H Ch Stricker; Miriam C J M Sturkenboom
Journal:  Drug Saf       Date:  2012-04-01       Impact factor: 5.606

3.  Antimicrobials and the risk of torsades de pointes: the contribution from data mining of the US FDA Adverse Event Reporting System.

Authors:  Elisabetta Poluzzi; Emanuel Raschi; Domenico Motola; Ugo Moretti; Fabrizio De Ponti
Journal:  Drug Saf       Date:  2010-04-01       Impact factor: 5.606

4.  Performance of Stratified and Subgrouped Disproportionality Analyses in Spontaneous Databases.

Authors:  Suzie Seabroke; Gianmario Candore; Kristina Juhlin; Naashika Quarcoo; Antoni Wisniewski; Ramin Arani; Jeffery Painter; Philip Tregunno; G Niklas Norén; Jim Slattery
Journal:  Drug Saf       Date:  2016-04       Impact factor: 5.606

5.  Stratification for spontaneous report databases.

Authors:  Johan Hopstadius; G Niklas Norén; Andrew Bate; I Ralph Edwards
Journal:  Drug Saf       Date:  2008       Impact factor: 5.606

6.  Stratification for spontaneous report databases.

Authors:  Stephen J W Evans
Journal:  Drug Saf       Date:  2008       Impact factor: 5.606

7.  Data-driven prediction of drug effects and interactions.

Authors:  Nicholas P Tatonetti; Patrick P Ye; Roxana Daneshjou; Russ B Altman
Journal:  Sci Transl Med       Date:  2012-03-14       Impact factor: 17.956

8.  Utilization of chi-square statistics for screening adverse drug-drug interactions in spontaneous reporting systems.

Authors:  Masahiko Gosho; Kazushi Maruo; Keisuke Tada; Akihiro Hirakawa
Journal:  Eur J Clin Pharmacol       Date:  2017-03-09       Impact factor: 2.953

9.  Performance of pharmacovigilance signal-detection algorithms for the FDA adverse event reporting system.

Authors:  R Harpaz; W DuMouchel; P LePendu; A Bauer-Mehren; P Ryan; N H Shah
Journal:  Clin Pharmacol Ther       Date:  2013-02-11       Impact factor: 6.875

10.  Signal Detection for Recently Approved Products: Adapting and Evaluating Self-Controlled Case Series Method Using a US Claims and UK Electronic Medical Records Database.

Authors:  Xiaofeng Zhou; Ian J Douglas; Rongjun Shen; Andrew Bate
Journal:  Drug Saf       Date:  2018-05       Impact factor: 5.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.